Fiebrig et al., 1997 - Google Patents
Colloidal gold and colloidal gold labelled wheat germ agglutinin as molecular probes for identification in mucin/chitosan complexesFiebrig et al., 1997
View PDF- Document ID
- 369879741113286189
- Author
- Fiebrig I
- Vårum K
- Harding S
- Davis S
- Stokke B
- Publication year
- Publication venue
- Carbohydrate polymers
External Links
Snippet
Polyelectrolyte complex formation between pig gastric mucin and chitosan and its implications to mucoadhesion have recently been studied using techniques such as analytical ultracentrifugation, static light scattering and turbidimetry (Fiebrig, I., Harding, SE …
- 229920001661 Chitosan 0 title abstract description 83
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48961—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the conjugate being in the form of a host-guest, i.e. being an inclusion complex, e.g. clathrate, cavitate, fullerene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Omidi et al. | Modification of chitosan and chitosan nanoparticle by long chain pyridinium compounds: Synthesis, characterization, antibacterial, and antioxidant activities | |
| Li et al. | Drug carrier systems based on water-soluble cationic β-cyclodextrin polymers | |
| Fiebrig et al. | Transmission electron microscopy studies on pig gastric mucin and its interactions with chitosan | |
| Funami et al. | Effects of some anionic polysaccharides on the gelatinization and retrogradation behaviors of wheat starch: Soybean-soluble polysaccharide and gum arabic | |
| Filipović-Grčić et al. | Chitosan microspheres with hydrocortisone and hydrocortisone–hydroxypropyl-β-cyclodextrin inclusion complex | |
| Akiyoshi et al. | Self-association of cholesteryl-bearing poly (L-lysine) in water and control of its secondary structure by host− guest interaction with cyclodextrin | |
| Montanari et al. | Hyaluronic acid nanohydrogels as a useful tool for BSAO immobilization in the treatment of melanoma cancer cells | |
| JP4566739B2 (en) | Aqueous dispersions consisting of nanometer or micrometer size particles for compound encapsulation | |
| Sombra et al. | Development of amphotericin B-loaded propionate Sterculia striata polysaccharide nanocarrier | |
| JP2002514663A (en) | Aloe pectin | |
| Alamdarnejad et al. | Synthesis and characterization of thiolated carboxymethyl chitosan-graft-cyclodextrin nanoparticles as a drug delivery vehicle for albendazole | |
| Ammar et al. | Chitosan/cyclodextrin nanoparticles as drug delivery system | |
| JP2004532097A (en) | Water-soluble esterified hydrocolloid | |
| Kaewprapan et al. | Enzymatically degradable nanoparticles of dextran esters as potential drug delivery systems | |
| US6576261B1 (en) | Potentiation of inclusion complex formation of cyclodextrin derivatives | |
| Fiebrig et al. | Colloidal gold and colloidal gold labelled wheat germ agglutinin as molecular probes for identification in mucin/chitosan complexes | |
| Luzardo‐Álvarez et al. | Preparation and characterization of β‐cyclodextrin‐linked chitosan microparticles | |
| Pariot et al. | Cross-linked β-cyclodextrin microcapsules: preparation and properties | |
| JP2021046392A (en) | Method for preparing pharmaceutical composition and pharmaceutical composition | |
| Gomes et al. | Tweaking the mechanical and structural properties of colloidal chitosans by sonication | |
| Jansook et al. | Effect of self-aggregation of γ-cyclodextrin on drug solubilization | |
| Omrani et al. | New cyclodextrin-based supramolecular nanocapsule for codelivery of curcumin and gallic acid | |
| Chen et al. | Development of a chitosan‐based nanoparticle formulation for delivery of a hydrophilic hexapeptide, dalargin | |
| Sui et al. | Self-assembly of an amphiphilic derivative of chitosan and micellar solubilization of puerarin | |
| JPS6327440A (en) | Glucosylated branched cyclodextrin-containing composition |